3 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Bottom 1%
#5533 out of 5539 analysts
Average Return
-18.21%
Win Rate
27%85 out of 316
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-03 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-24 - 2024-11-22 | Buy |
Aim Immunotech IncAIM | +583.49% | $0.22 | $1.49 | 2024-12-10 - 2025-12-09 | Buy |
Quantum Computing IncQUBT | +318.80% | $2.66 | $11.14 | 2024-11-13 - 2025-11-12 | Buy |
Duos Technologies Group IncDUOT | +234.24% | $2.57 | $8.59 | 2024-06-07 - 2025-06-06 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Aether Holdings IncATHR | 1 | Buy | $10.00 | +263.64% | Initiates Coverage On | 10 days ago |
Sintx Technologies IncSINT | 6 | Buy | $12.50 | +503.86% | Maintains | 14 days ago |
Nrx Pharmaceuticals IncNRXP | 9 | Buy | $50.00 | +1,751.85% | Maintains | 14 days ago |
Atossa Therapeutics IncATOS | 9 | Buy | $25.00 | +876.56% | Maintains | 14 days ago |
Aytu Biopharma IncAYTU | 5 | Buy | $15.00 | +653.77% | Maintains | 15 days ago |
Allarity Therapeutics IncALLR | 6 | Buy | $11.00 | +1,164.37% | Maintains | a month ago |
Banzai International IncPARA | 10 | Buy | $24.00 | +4,103.15% | Maintains | a month ago |
Surgepays IncSURG | 12 | Buy | $3.75 | +2,829.69% | Maintains | a month ago |
Knightscope IncKSCP | 8 | Buy | $21.00 | +3,325.77% | Maintains | a month ago |
Nexttrip IncNTRP | 3 | Buy | $7.75 | +323.50% | Maintains | a month ago |
Duos Technologies Group IncDUOT | 11 | Buy | $24.00 | +274.41% | Maintains | a month ago |
Pro Dex IncPDEX | 6 | Buy | $74.00 | +18.84% | Maintains | a month ago |
Outlook Therapeutics IncOTLK | 9 | Buy | $10.50 | +1,761.70% | Maintains | a month ago |
Cerenome IncCNSY | 9 | Buy | $43.00 | +2,371.26% | Maintains | a month ago |
Genasys IncGNSS | 8 | Buy | $5.00 | +273.13% | Maintains | 2 months ago |
Renovorx IncRNXT | 11 | Buy | $14.50 | +1,160.87% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 11 | Buy | $9.50 | +1,467.66% | Maintains | 2 months ago |
Pavmed IncPAVM | 11 | Buy | $57.00 | +2,059.09% | Maintains | 2 months ago |
Intrusion IncINTZ | 9 | Buy | $9.00 | +1,286.75% | Maintains | 2 months ago |
Myomo IncMYO | 8 | Buy | $10.50 | +713.95% | Maintains | 2 months ago |
Igc Pharma IncIGC | 11 | Buy | $6.00 | +2,164.15% | Maintains | 2 months ago |
Quantum Computing IncQUBT | 8 | Buy | $32.00 | +365.79% | Maintains | 2 months ago |
Gri Bio IncGRI | 8 | Buy | $27.00 | +1,641.94% | Maintains | 2 months ago |
TravelzooTZOO | 8 | Buy | $20.00 | +276.65% | Maintains | 2 months ago |
Aemetis IncAMTX | 8 | Buy | $20.00 | +1,182.05% | Maintains | 2 months ago |
Aim Immunotech IncAIM | 7 | Buy | $7.00 | +4,017.65% | Maintains | 2 months ago |
Cingulate IncCING | 7 | Buy | $44.00 | +832.20% | Maintains | 2 months ago |
Alzamend Neuro IncALZN | 8 | Buy | $26.00 | +1,825.93% | Maintains | 2 months ago |
Synergy Chc CorpSNYRQ | 3 | Buy | $3.75 | +4,066.67% | Maintains | 4 months ago |
Endra Life Sciences IncNDRA | 6 | Buy | $25.00 | +396.03% | Maintains | 4 months ago |
Maison Solutions IncMSS | 4 | Buy | $162.50 | +10,383.87% | Maintains | 6 months ago |
Society Pass IncorporatedSOPAQ | 7 | Buy | $22.50 | +29,505.26% | Maintains | 10 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | N/A | Maintains | a year ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | N/A | Maintains | a year ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | N/A | Maintains | a year ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | N/A | Maintains | a year ago |
Groupon IncGRPN | 8 | Buy | $19.00 | N/A | Maintains | 2 years ago |
Daxor CorpDXR | 3 | Buy | $25.00 | N/A | Maintains | 2 years ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | N/A | Maintains | 2 years ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | N/A | Maintains | 2 years ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 3 years ago |
Booking Holdings IncBKNG | 2 | Buy | $97,500.00 | N/A | Maintains | 3 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 3 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 3 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 3 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 4 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 4 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 4 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 4 years ago |
Realloys IncALOY | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Stablecoin Development CorpSDEV | 3 | Buy | $24,500.00 | N/A | Maintains | 4 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 5 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 5 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 5 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.